Haemonetics Corporation (HAE)
NYSE·Healthcare·Medical - Instruments & Supplies
$59.96
-0.86%
Mkt Cap $2.82B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $331.92M | $339.00M | +2.13% | $1.27 | $1.31 | +3.15% | — | — |
| Q4 2025 Nov 6, 2025 | $329.77M | $327.31M | -0.75% | $1.12 | $1.27 | +13.39% | — | — |
| Q3 2025 Aug 7, 2025 | $320.01M | $321.39M | +0.43% | $1.01 | $1.10 | +8.91% | — | — |
| Q2 2025 May 8, 2025 | $312.47M | $330.60M | +5.80% | $1.22 | $1.24 | +1.64% | — | — |
| Q1 2025 Feb 6, 2025 | $354.46M | $348.54M | -1.67% | $1.18 | $1.19 | +0.85% | — | — |
| Q4 2024 Nov 7, 2024 | $342.65M | $345.51M | +0.83% | $1.09 | $1.12 | +2.75% | — | — |
| Q3 2024 Aug 8, 2024 | $335.38M | $336.17M | +0.24% | $1.03 | $1.02 | -0.97% | — | — |
| Q2 2024 May 9, 2024 | $329.11M | $343.29M | +4.31% | $0.88 | $0.90 | +2.27% | — | — |
| Q1 2024 Feb 8, 2024 | $320.29M | $336.25M | +4.98% | $0.97 | $1.04 | +7.22% | — | — |
| Q4 2023 Nov 2, 2023 | $313.12M | $318.18M | +1.62% | $0.94 | $0.99 | +5.32% | — | — |
| Q3 2023 Aug 8, 2023 | $292.69M | $311.33M | +6.37% | $0.73 | $1.05 | +43.84% | — | — |
| Q2 2023 May 11, 2023 | $289.64M | $304.42M | +5.10% | $0.68 | $0.77 | +13.24% | — | — |
| Q1 2023 Feb 7, 2023 | $299.56M | $305.30M | +1.92% | $0.79 | $0.85 | +7.59% | — | — |
| Q4 2022 Nov 7, 2022 | $269.22M | $297.49M | +10.50% | $0.67 | $0.83 | +23.88% | — | — |
| Q3 2022 Aug 10, 2022 | $249.00M | $261.46M | +5.00% | $0.53 | $0.58 | +9.43% | — | — |
| Q2 2022 May 10, 2022 | $257.11M | $265.00M | +3.07% | $0.60 | $0.65 | +8.33% | — | — |
| Q1 2022 Feb 8, 2022 | $265.39M | $259.77M | -2.12% | $0.75 | $0.84 | +12.00% | — | — |
| Q4 2021 Nov 9, 2021 | $239.99M | $239.90M | -0.04% | $0.63 | $0.60 | -4.76% | — | — |
| Q3 2021 Aug 11, 2021 | $228.53M | $228.53M | +0.00% | $0.47 | $0.50 | +6.38% | — | — |
| Q2 2021 May 13, 2021 | $223.05M | $225.03M | +0.89% | $0.67 | $0.46 | -31.34% | — | — |